In addition, miR‐125b is up‐regulated in cervical cancer and it exerts its oncogenic function by targeting the 3′ UTR of high mobility group A (HMGA1), a tumour suppressor in the PI3K/Akt signalling pathway.45 Here, PIK3CB is linked to neoplasm.